Suggestions
Michael E Ivan, MD, MBS, FAANS
Associate Professor - Dept of Neurological Surgery at University of Miami
Michael E. Ivan, MD, MBS, FAANS, is a prominent neurosurgeon and scientist at the University of Miami's Miller School of Medicine, where he serves as the Director of Skull Base Surgery. He specializes in complex brain tumor and skull base surgeries, focusing on conditions such as meningiomas and pituitary tumors.
Education and Qualifications
- Medical Degree (MD): Obtained from a recognized institution.
- Master of Biomedical Sciences (MBS): Furthering his expertise in medical science.
- Fellowship in the American Association of Neurological Surgeons (FAANS): Recognizing his advanced training and contributions to the field.
Professional Role
Dr. Ivan is an Associate Professor in the Department of Neurological Surgery and is actively involved in research related to neuro-oncology. His work includes both clinical practice and academic contributions, with numerous publications in the field of neurosurgery.
Research Interests
His research primarily revolves around:
- Neuro-oncology
- Brain Tumors
- Skull Base Tumors
Dr. Ivan is noted for his contributions to understanding and treating complex neurological conditions, making significant strides in surgical techniques and patient care.
Online Presence
He maintains a professional profile on LinkedIn under the username michaeleivan, where he connects with peers and shares insights related to his field.
In summary, Dr. Michael E. Ivan is a distinguished figure in neurosurgery, particularly known for his expertise in skull base surgery at the University of Miami.
Highlights
Hot off the press! Super proud of our team for their groundbreaking work analyzing the use of MRSpec to predict glioma progression. This study is a major milestone—the first of its kind to reveal radiographically occult glioma progression up to 8 months before MRI gadolinium detection. Early detection means earlier treatment decisions, even before symptoms arise. This research is a significant advancement in predicting glioblastoma recurrence, which can help guide treatment and improve patient outcomes.
Check out the full study on the open access site provided by the JNO: [https://lnkd.in/etrw3sM3).
Plus, you can apply your own MRSpec data using the Miami Glioma Prediction Map here: [https://lnkd.in/eQmaQFKW).
@ashishshahmd @camrivera8 @shovanbhatia
@ricardokomotar @neuro.morell @ldaggubati @drmartinmerenzon @evanluthermd @jay.chandar @alevy96 @yourfavoritemetzler @chandler_berke @um_svilab @umneurosurgery @sylvestercancer @umiamimedicine @jneurooncol @nstumorsection
That concludes two inspiring days at #Luminaite2024, filled with thought-provoking discussions on the future landscape of neurosurgery with some of the most innovative faculty in the world. The collaboration of AI with surgical decisions, medical devices, education, and patient selection holds the potential to enhance our treatments—ensuring they become more predictable, efficient, effective, and safe #NeurosurgeryInnovation #aiadvancements Medtronic Brain and Spine Therapies
